Valeant, Par End Patent Suit Over Colitis Treatment
By Dani Kass ( July 26, 2016, 1:43 PM EDT) -- Par Pharmaceuticals Inc. reached a settlement Monday in a patent infringement suit brought by Valeant Pharmaceuticals International and Cosmo Pharmaceuticals Ltd. in Delaware federal court over Par's attempt to make a generic of the colitis treatment Uceris....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.